AS

Amol Suresh Povar

Active Director Designated Partner DIN 10115525
DIN 10115525 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Amol Suresh Povar

Data last updated:

Amol Suresh Povar is a Designated Partner at Aimtrans Pharmaceuticals Llp (since 2024) and Director at Cromtrans Pharma Private Limited (since 2023). The companies operate in Pharma.

DIN 10115525
Primary Designation Designated Partner
Industry Pharma
First Appointment 12 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Jul 20242024Active
Cromtrans Pharma Private Limited U47721PN2023PTC219453
Director12 Apr 20232023Active

Board colleagues of Amol Suresh Povar

Directorship timeline

Open interactive timeline →
Cromtrans Pharma Private Limited
Aimtrans Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Amol Suresh Povar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amol Suresh Povar

Amol Suresh Povar currently holds 2 directorships: Aimtrans Pharmaceuticals Llp (Designated Partner, since 25 Jul 2024); Cromtrans Pharma Private Limited (Director, since 12 Apr 2023).

Amol Suresh Povar was first appointed on 12 Apr 2023 as Director at Cromtrans Pharma Private Limited. The most recent appointment on record is 25 Jul 2024 at Aimtrans Pharmaceuticals Llp.

The current boards of Amol Suresh Povar's companies include Smita Amol Powar (Aimtrans Pharmaceuticals Llp), Mangesh Mahadev Sankapal (Cromtrans Pharma Private Limited), Sameer Ismail Anure (Cromtrans Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available